In Publikationen
back BACK
SARS-CoV2 wild type and mutant spe­ci­fic humo­ral and T cell immu­nity is supe­rior after vac­ci­na­tion than after natu­ral infection.
Auto­ma­ted, flow-based che­mi­lumi­ne­s­cence micro­ar­ray immu­n­o­as­say for the rapid mul­ti­plex detec­tion of IgG anti­bo­dies to SARS-CoV-2 in human serum and plasma (CoV­Ra­pid CL-MIA)